Buclizine dihydrochloride is a hydrochloride salt that is obtained by reaction of buclizine with 2 equivalents of hydrogen chloride. Among its listed roles, it functions as a central nervous system depressant, a local anaesthetic, a histamine antagonist, a cholinergic antagonist and an antiemetic. It is grouped under the following drug class(es): Antiemetics. Its therapeutic use is listed as antihistamines. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Longifene, Equivert, Postafeno and Softran. Its PubChem CID is 65463.
Buclizine hydrochloride
| CAS No | 129-74-8 |
|---|---|
| Molecular Formula | C28H35Cl3N2 |
| Molecular Weight | 505.9 g/mol |
| Synonyms | 1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine;dihydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Buclizine dihydrochloride is a hydrochloride salt that is obtained by reaction of buclizine with 2 equivalents of hydrogen chloride. Among its listed roles, it functions as a central nervous system depressant, a local anaesthetic, a histamine antagonist, a cholinergic antagonist and an antiemetic.
The listed CAS number is 129-74-8.
The listed molecular formula is C28H35Cl3N2.
The listed molecular weight is 505.9 g/mol.
1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine;dihydrochloride.
The source lists Longifene, Equivert, Postafeno and Softran.